Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Progestogen-only contraception"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Osteoporosis International. 31:1801-1806
Our study demonstrated that progestogen-only oral and intrauterine contraceptives are not associated with fracture risk independent from age. The use of progestogen-only contraception, resulting in a hypoestrogenic state, has been associated with imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e66f9f19c6c82145f5ae9d7468f8ea65
https://doi.org/10.1007/s00198-020-05437-6
https://doi.org/10.1007/s00198-020-05437-6
Autor:
Katie Boog, Michelle Cooper
Publikováno v:
Practice Nursing. 30:528-535
Hormonal contraception can provide reliable protection against unintended pregnancy, as well as a broad range of non-contraceptive benefits. Dr Michelle Cooper and Dr Katie Boog give an overview of these benefits Beyond their primary role of preventi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daf684922685bc206aa34bdaf857af68
https://doi.org/10.12968/pnur.2019.30.11.528
https://doi.org/10.12968/pnur.2019.30.11.528
Autor:
Inger Sundström-Poromaa
Publikováno v:
Trends in Andrology and Sexual Medicine ISBN: 9783030709310
The interest in how, and if, hormonal contraceptives influence mood has increased over the past years. Mood symptoms, such as depressive symptoms, irritability, anxiety, and mood swings, are becoming a clinical problem for many hormonal contraceptive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c75f64d4479bef0f767a0f260d81e644
https://doi.org/10.1007/978-3-030-70932-7_5
https://doi.org/10.1007/978-3-030-70932-7_5
Publikováno v:
Skouby, S O & Sidelmann, J J 2019, ' Impact of progestogens on hemostasis ', Hormone Molecular Biology and Clinical Investigation, vol. 37, no. 2, 20180041 . https://doi.org/10.1515/hmbci-2018-0041
Combined hormonal contraception containing estrogen and progestogen and postmenopausal hormone therapy with estrogen ± progestogen are reported risk factors for venous thrombosis. The thrombotic risk varies by estrogen dose and type of progestogen.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4ea0b5f74db89298556936fc173293f
https://pubmed.ncbi.nlm.nih.gov/30447140
https://pubmed.ncbi.nlm.nih.gov/30447140
Publikováno v:
The Obstetrician & Gynaecologist. 19:289-297
Key content There have been a number of recent advances and an increase in the number of contraceptive methods available to perimenopausal women. Other relevant issues, including transition to and diagnosis of menopause, the use of hormone replacemen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8a43129db082037dd9549455befa408
https://doi.org/10.1111/tog.12416
https://doi.org/10.1111/tog.12416
Autor:
C Tassorelli, Alessandro Kunder Franco, Roberta Rossini, Silvia Martella, Alessandra Inzoli, Lara Tiranini, Manuela Piccinino, Emanuela Brambilla, Grazia Sances, Rossella E. Nappi
Publikováno v:
Menstrual Cycle Related Disorders ISBN: 9783030143572
Hormonally related headaches relate to reproductive milestones and to prescription of hormonal compounds for contraception, treatment of reproductive conditions, and relief of climacteric symptoms. Counseling should take into account the risk-benefit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be9cda709ac6d07b7f59ddb84ebcc7dd
https://doi.org/10.1007/978-3-030-14358-9_8
https://doi.org/10.1007/978-3-030-14358-9_8
Autor:
Kathryn M. Curtis, Melissa E. Paulen
Publikováno v:
Contraception. 80:391-408
Background Currently, there is a generally accepted 2-week grace period for women returning early/late for reinjection of either depot medroxyprogesterone acetate (DMPA) or norethisterone enantate (NET-EN). This systematic review evaluates the eviden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c074e33163aca3414a1791995e772976
https://doi.org/10.1016/j.contraception.2009.03.023
https://doi.org/10.1016/j.contraception.2009.03.023
Publikováno v:
Journal de Gynécologie Obstétrique et Biologie de la Reproduction. 37:637-660
Despite the lack of complete data concerning their effects, the use of progestin-only contraception is increasing in France (particularly the intra-uterine device, the subdermal implantation, and microprogestins). These prescriptions include a broad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::811c1b1bc69072c01d310d5cf0c1b8f7
https://doi.org/10.1016/j.jgyn.2008.06.013
https://doi.org/10.1016/j.jgyn.2008.06.013
Autor:
Emma Nash
Publikováno v:
InnovAiT: Education and inspiration for general practice. 1:508-519
Progestogen-only contraception refers to the methods of contraception that contain a synthetic form of progesterone. In 2005/2006, 10% of all women aged 16–49 in the UK were using progestogen-only contraception. Such contraceptive methods include t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53d9ea24836c8bab22ac86ed1e8a4721
https://doi.org/10.1093/innovait/inn090
https://doi.org/10.1093/innovait/inn090